GlassScriptPhysician profile
Omar Baring Cabahug
NPI 1891895488
$7,343.09
in general payments reported to CMS, 2019-2025
52 companies · $1,661 in 2025
The $1,661 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $739 · 2021: $1,049 · 2022: $1,039 · 2023: $1,022 · 2024: $1,441 · 2025: $1,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,124.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,884.72 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Novartis Pharmaceuticals Corporation | $503.27 | 2020-2025 | |
| Lundbeck LLC | $449.91 | 2019-2025 | Vyepti, Rexulti |
| Pfizer INC. | $406.06 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $376.53 | 2019-2025 | Nuplazid, Daybue |
| Allergan, INC. | $325.88 | 2020-2021 | |
| Celgene Corporation | $296.39 | 2021-2025 | Zeposia |
| Biogen, INC. | $262.07 | 2019-2025 | Vumerity, Tysabri |
| Sk Life Science, INC. | $252.42 | 2020-2024 | |
| Lilly USA, LLC | $209.21 | 2021-2025 | Kisunla, Amyvid |
| Biohaven Pharmaceutical Holding Company LTD. | $188.43 | 2022 | |
| Argenx US, INC. | $183.82 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Eisai INC. | $177.88 | 2023-2025 | |
| Ucb, INC. | $150.39 | 2019-2025 | Nayzilam |
| Amgen INC. | $127.39 | 2021-2022 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Cabahug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.